Evidence map›Paper›PMID 40278487›Full record

ReviewNanomaterials (Basel, Switzerland)2025

Stealth Materials Based on Laser-Induced Graphene: Developments and Challenges.

Xinjian Lu, Ruige Su, Guiyong Chen, Wenxin Li, Misheng Liang, Rui You

Abstract readReview
In one paragraph

Review in Nanomaterials (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Nonlinear Optics in Low-Dimensional Nanomaterials.Nanomaterials (Basel, Switzerland) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Xinjian LuAVIC Chengdu Aircraft Industrial (Group) Co., Ltd., Chengdu 610092, China.
Ruige SuLaboratory of the Intelligent Microsystem, Beijing Information Science and Technology University, Beijing 100192, China.
Guiyong ChenAVIC Chengdu Aircraft Industrial (Group) Co., Ltd., Chengdu 610092, China.
Wenxin LiAVIC Chengdu Aircraft Industrial (Group) Co., Ltd., Chengdu 610092, China.
Misheng LiangLaboratory of the Intelligent Microsystem, Beijing Information Science and Technology University, Beijing 100192, China.ORCID 0009-0007-6445-3761
Rui YouLaboratory of the Intelligent Microsystem, Beijing Information Science and Technology University, Beijing 100192, China.ORCID 0000-0003-2668-8221

Funding

Beijing Nova Program 20230484473Beijing Outstanding Young Scientist Program JWZQ20240101028National Natural Science Foundation of China 62204020
6 · The paper itself

Abstract

Laser-induced graphene (LIG) has become a promising stealth material due to its excellent electromagnetic loss characteristics in the terahertz and microwave bands (2-18 Ghz) and the advantages of low-cost large-scale manufacturing. With the rapid advancement of electromagnetic detection technologies toward multispectral and high-dynamic-range capabilities, there is an increasing demand for LIG-based stealth materials with superior absorption performance. The synergistic design of functional material doping and structural configurations has been identified as a critical approach to achieve high electromagnetic shielding performance in LIG-based composites. This article briefly reviews the developmental progress of LIG-based electromagnetic stealth materials, with a particular emphasis on doping technologies and shielding mechanisms tailored for stealth applications. Furthermore, we propose potential future development pathways for LIG-based stealth materials to facilitate their transition toward broader practical applications.

Indexed as

broadband absorbing materialelectromagnetic interferencelaser-induced graphenemetasurfacemultispectral absorbing material

Identifiers

PMID40278487
PMCPMC12029413

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.